Student Outcomes

Student Outcomes:
  • 73% of QSB graduates who applied to Ph.D. programs have been admitted (Northwestern IBiS, U of Washington, UC Irvine, Washington University St. Louis, McGill University - Canada, Humboldt University - Germany)
  • Some students have specifically chosen to go to industry (Bain and Company, and Vizient, Inc.) and did not apply for Ph.D. programs 
  • Students who have not gone into Ph.D. programs have gone onto productive careers in academic research and biotech (Institute of Materia Medica -China, New Bellus - Taiwan)
Class of 2022 (five students)
  • 3 in Ph.D. programs: 2 Northwestern University's IBiS program, 1 Georgia Tech
  • 2 currently in QSB program
Class of 2021 (four students)
  • 1 in Ph.D. program: Northwestern University’s IBiS program
  • 1 in biotech (Vizient, Inc)
  • 1 in consulting (Bain and Co.)
  • 1 gap year
Class of 2020 (four students)
  • 3 in Ph.D. programs: 2 in Northwestern University’s IBiS program, 1 in Humboldt University (Germany)
  • 1 in biotech industry: New Bellus (Taiwan)
Class of 2019 (six students)
  • 4 in Ph.D. programs:  UC Irvine, University of Washington, Washington University St. Louis, McGill University - Canada
  • 1 in academic research: Institute of Materia Medica - Chinese Academy of Medical Sciences, Shenzhen Institute of Advanced Technology (China)
  • 1 no current information